NHS Rationing of ADHD Assessments Raises Serious Concerns
January 20, 2026 – A growing crisis is unfolding within the UK’s National Health Service (NHS) as mounting financial pressures lead too covert restrictions on access to ADHD assessments. Investigations reveal that over half of NHS Integrated Care Boards (ICBs) in England have imposed limits on the number of individuals who can be assessed for Attention Deficit Hyperactivity Disorder (ADHD) during 2025-26, with a disturbing lack of transparency towards both healthcare professionals and patients. This practice, intended to curb spending, is sparking outrage from patient advocacy groups and raising serious ethical questions about equitable access to healthcare.
Secret Restrictions and Communication Breakdown
Freedom of Data (FOI) requests submitted by the charity ADHD UK have uncovered the extent of these restrictions. The findings show that 22 out of 42 ICBs are actively limiting ADHD assessments. Crucially,a notable proportion – 13 out of those 22 – failed to inform general Practitioners (GPs) about these limits,and 12 did not communicate the changes to patients already awaiting assessment . This lack of communication is fueling accusations that the NHS is deliberately concealing the rationing of care.
Henry Shelford, Chief Executive of ADHD UK, condemned the practice, stating: “Waiting times for assessments are already horrendously long and it’s shocking to see how the NHS is further rationing peopel’s care to save money. It’s cruel but increasingly widespread. We’re seeing ICBs curb patients’ access to ADHD assessment without telling GPs or patients that they are doing this, and without having made any assessment of the consequences.” He further emphasized the ethical implications, arguing, “The NHS should be ashamed of itself for such secrecy and hiding the fact that they are depriving people of this vital type of care.”
Years-Long Waits and the Economic Cost of Untreated ADHD
The situation is particularly alarming given the already extensive waiting lists for ADHD assessments. patients in England currently face an average wait of eight years for an appointment . Further limiting assessment capacity will inevitably exacerbate these delays, leaving countless individuals struggling without a diagnosis and appropriate support.
The consequences of untreated ADHD extend far beyond individual hardship. A recent report by the goverment’s ADHD taskforce highlighted the enormous economic burden associated with undiagnosed and unsupported ADHD, estimating a staggering £17 billion annual cost to the nation. This figure encompasses expenses related to crime, educational underachievement, substance misuse, suicide, and mental ill-health . Early diagnosis and intervention are demonstrably cost-effective in the long run, mitigating these far-reaching societal impacts.
understanding ADHD: A growing Public Health Concern
ADHD is a neurodevelopmental condition characterized by inattention, hyperactivity, and impulsivity. While often associated with childhood, ADHD persists into adulthood for many individuals. Accurate diagnosis is critical for accessing appropriate treatment, which can include medication, therapy, and lifestyle modifications. Untreated ADHD can significantly impair an individual’s ability to function in various aspects of life, affecting their education, employment, relationships, and overall well-being.
ICB Responses and NHS England’s Position
North Central London ICB has acknowledged implementing “indicative activity plans” (IAPs) – effectively capping the number of ADHD and autism assessments it will fund. However, the ICB admitted to conducting an impact assessment without proactively communicating the changes to either GPs or patients. Similar practices have been identified in other regions, including Kent and Medway, and Bedfordshire, Luton and Milton Keynes.
Despite the growing concerns, NHS england maintains that individuals seeking assessment can still join waiting lists and that GPs can continue to make referrals when clinically appropriate. A spokesperson stated that the payment scheme proposals are not intended to restrict access and are aimed at improving the sustainability, consistency, and quality of ADHD services.This assertion, however, directly contradicts the findings of ADHD UK and the experiences reported by patients and healthcare professionals on the ground.
Broader Context: Rising Diagnoses and the Demand for Mental Health Services
The current crisis is unfolding against a backdrop of increasing awareness and diagnosis of ADHD, and also a broader rise in reported cases of autism and other mental health conditions. This surge in diagnoses might potentially be attributed to a number of factors, including reduced stigma, increased recognition of the condition in adults, and improved diagnostic tools.
Addressing this growing demand requires substantial investment in mental health services and a commitment to accessible and equitable care. The government has recently commissioned a review, led by Health Secretary Wes Streeting, to examine the reasons behind the recent increase in diagnoses of ADHD, autism, and mental illness, and to explore solutions to address the escalating pressures on the system .
the Financial Strain on ADHD Services
Adding to the complexity of the situation, the Guardian recently reported that NHS England is already over budget by £164 million for ADHD services this year, largely due to the soaring demand for assessments . This financial strain is undoubtedly contributing to the current rationing measures, but critics argue that short-term cost-cutting cannot justify compromising the health and well-being of vulnerable individuals.
The current situation demands a fundamental reassessment of how ADHD services are funded and delivered within the NHS. Increased investment, improved transparency, and a commitment to patient-centered care are essential to ensure that everyone who needs it can access timely and appropriate assessment and support.
Key Takeaways
* Over half of NHS ICBs in England are limiting ADHD assessments.
* Many ICBs are failing to inform GPs and patients about these restrictions.
* Waiting times for assessments already average eight years.
* Untreated ADHD carries a significant economic and social cost.
* the NHS needs to increase investment in ADHD services and improve transparency.
The ongoing restrictions on ADHD assessments represent a critical challenge to the principles of equitable healthcare. As the crisis deepens, it is imperative that policymakers and healthcare leaders prioritize the needs of individuals with ADHD and ensure that they receive the support they deserve.